Advances in Herbal Research | online ISSN 2209-1890
Editorial Structure
Editorial Board
All submissions to Australian Herbal Insight are assessed initially by the Editor-in-Chief and, if considered to lie within the journal´s scope and to be of sufficient quality, are sent for external peer review, in consultation with members of the Editorial Board. This board comprises scientists and researchers whose expertise spans topics relevant to the journal´s scope. Associate Editors make recommendations about publication of articles in the journal but the final decision is the responsibility of the Editor-In-Chief.
Editor-In-Chief
Amin Malik Shah Abdul Majid, Ph.D.
Professor, Chairman, Eman Research Ltd, Canberra, Australia
Dr. Amin Malik Shah Abdul Majid is a renowned scientist specializing in botanical drugs, angiogenesis, cancer research, phytomedicine, and DNA-binding agents. Dr. Majid has made significant contributions to natural product-based therapeutics, anti-cancer drug discovery, and nanomedicine. Dr. Majid’s work has garnered over 3,500 citations, reflecting his impactful research in cancer biology, particularly the antiangiogenic and cytotoxic properties of natural compounds. His groundbreaking studies on essential oils, silver-based complexes, and xanthones have advanced innovative approaches to cancer treatment and translational medicine.
Editor-in-Chief's assistant
Zeyad D. Nasar, PhD
University of Adelaide
Australia
Executive Editors
Md Shamsuddin Sultan Khan, Ph.D.
VP, Neo7bioscience Inc., United States
Dr. Md Shamsuddin Sultan Khan is a distinguished researcher specializing in pharmacology, computational biology, cancer biology, transcriptomics, and medicinal chemistry. Currently associated with Neo7bioscience Inc. in the USA, his research spans diverse areas including angiogenesis, therapeutic drug design, and natural product pharmacology. Dr. Khan's impactful work is reflected in over 700 citations and multiple high-impact publications. His notable studies include investigations into anti-cancer therapies, bioactive compounds, and IL17A-targeted drug development. By integrating computational models and experimental biology, Dr. Khan advances precision medicine and translational research, contributing significantly to innovative therapeutic approaches and biopharmaceutical development.
Section Editors and Associate Editors
Chris Cazzonelli, Ph.D.
Associate Professor, Western Sydney University, Australia
Dr. Christopher Cazzonelli, an Associate Professor of Plant Molecular Biology at the Hawkesbury Institute for the Environment, is a globally recognized expert in carotenoid regulation, epigenetics, and plant stress responses. His pioneering research explores the intricate regulation of carotenoid biosynthesis and its implications for plant development, environmental adaptability, and horticultural productivity. Dr. Cazzonelli has made significant contributions to understanding chromatin modification, apocarotenoid signaling, and mechanical stress in plants, bridging molecular biology and applied agriculture. His groundbreaking work on carotenoids extends to tree genomics and shorticulture, emphasizing sustainability and resilience in plant systems. His studies have garnered widespread acclaim and high citations, reflecting his impactful scientific contributions.
Infectious Disease Clinical, Health, Molecular Biology, Cancer, Angiogenesis
Clinical Research Associate, CTI Clinical Trial Services, Australia
Dr. Mohamed Khadeer Ahamed is a Clinical Research Associate II at CTI Clinical Trial and Consulting Services in Sydney, Australia, with over 15 years of experience in clinical research. A biochemist and pharmacologist, his expertise spans oncology, diabetes, and preclinical toxicology studies. Dr. Ahamed has contributed significantly to cancer biology, angiogenesis, and experimental pharmacology, focusing on natural products like Aquilaria crassna and Ficus deltoidea. He holds a PhD in Pharmacology from Kuvempu University and has authored several key papers on the anticancer, antioxidant, and antimicrobial properties of natural compounds, driving innovation in drug development and cancer research.
Medical Biochemistry, Immunology, Cancer
Prof Christoper Paris, Ph.D.
Australian National University, Australia
Emeritus Professor Chris Parish is an immunologist and leader of the Cancer and Vascular Biology Group at ANU's John Curtin School of Medical Research. He earned his PhD at The Walter & Eliza Hall Institute and has spent over 35 years advancing immunology. In the 1970s, he was the first to demonstrate the antagonistic relationship between cell-mediated immunity and antibody formation, a discovery central to the Th1/Th2 paradigm. His work on heparan sulfate and heparanase has led to the development of novel anti-cancer therapies, including PI-88. In 2005, he received the prestigious Ramaciotti Medal for Excellence in Biomedical Research for his groundbreaking contributions.
Nozlena Abdul Samad, Ph.D.
Associate Professor, Universiti Sains Malaysia, Malaysia
Dr. Nozlena Abdul Samad, is a Associate Professor at Universiti Sains Malaysia, specializes in cancer research, angiogenesis, and phytomedicine. Her pioneering work explores the anticancer potential of natural compounds, particularly through innovative drug delivery systems and nanomedicine. Dr. Samad’s notable studies on Moringa oleifera and Zerumbone have elucidated their mechanisms in suppressing tumor growth and angiogenesis. With a strong focus on the biomedical applications of plant-based therapies, she bridges traditional medicine with modern therapeutic advancements. Renowned for her systematic reviews and translational research, Dr. Samad’s contributions have significantly enriched the field of phytopharmacology and novel anticancer strategies.
Fouad Saleih Al-Suede, Ph.D.
Senior Scientist, Universiti Sains Malaysia, Malaysia
Dr. Fouad Saleh Resq Al-Suede is a Scientist in the field of pharmacology, experimental medicine, and advanced nutraceuticals. His work focuses on antiangiogenesis, cancer pathways, and the therapeutic potential of natural products. Dr. Al-Suede has made significant contributions to isolating and characterizing bioactive compounds from medicinal plants such as Kaempferia galanga and Orthosiphon stamineus. His research has elucidated molecular mechanisms underlying anti-inflammatory, anticancer, and pro-apoptotic effects, advancing innovative strategies for cancer treatment. With numerous high-impact publications, Dr. Al-Suede continues to bridge pharmacology and natural medicine, fostering novel approaches in oncology and precision therapeutics.
Molecular Biology, Cancer, Angiogenesis
Loiy Elsir Ahmed Hassan, Ph.D.
Senior Scientist, AstraZeneca Inc., United States
Dr. Loiy Esir Ahmed Hassan is a Scientist II AstraZeneca. He is a researcher in cancer biology, drug discovery, tumor angiogenesis, and preclinical pharmacology. His innovative work bridges the gap between natural product-based therapeutics and cancer therapy. With over 1,500 citations, Dr. Hassan has made significant strides in understanding the anticancer and anti-inflammatory properties of natural compounds, including cucurbitacins and essential oils. His research explores molecular mechanisms of tumor suppression, targeting pathways such as angiogenesis and apoptosis, advancing novel chemotherapeutic strategies. Dr. Hassan’s work continues to impact cancer treatment and translational medicine globally.
Oon Chern Ein, Ph.D.
Associate Professor, Oncologist Universiti Sains Malaysia, Malaysia
Dr. Chern Ein Oon is a molecular Oncologist at INFORMM, Universiti Sains Malaysia, specializing in targeted cancer therapies, Notch signaling, and tumor angiogenesis. Her impactful research, reflected in over 1,000 citations for her seminal work on molecular therapies, has advanced the understanding of cancer mechanisms and therapeutic strategies. Dr. Oon’s expertise extends to sirtuins and bioactive compound analysis, contributing to innovative approaches in combating tumorigenesis and metastasis. With a prolific academic record, she has co-authored groundbreaking studies on exosomal signaling, VEGF resistance, and apoptosis modulation, establishing herself as a leader in precision oncology and translational cancer research.
Aman Shah Bin Abdul Majid, Ph.D.
Professor, Quest International University, Malaysia
Prof. Dr. Aman Shah Abdul Majid, FRSB, is a distinguished academic and researcher in the Faculty of Medicine at the Centre for Angiogenesis and Natural Product Research. His work focuses on clinical research, natural product screening, angiogenesis, cell signaling, and neuroprotection. With expertise in cancer, antioxidant, and antimicrobial properties, Dr. Majid has contributed to numerous groundbreaking studies on medicinal plants, including Aquilaria crassna and Illicium verum. His research has been widely cited, and he has authored influential papers on the therapeutic potential of natural products. Dr. Majid is a prominent figure in pharmacology, advancing both fundamental and applied research.
Analytical Chemistry
Mohammed Adnan Iqbal, Ph.D.
Associate Professor, University of Agriculture Faisalabad, Pakistan
Dr. Muhammad Adnan Iqbal is an Associate Professor in the Department of Chemistry at the University of Agriculture Faisalabad. His research spans organometallics, coordination chemistry, and medicinal and environmental chemistry. Dr. Iqbal has made significant contributions to the development of silver-based complexes with anticancer, antioxidant, and antimicrobial properties. His studies also focus on the synthesis of novel metal complexes for biomedical applications, particularly in cancer treatment. Dr. Iqbal has co-authored over 80 publications in leading journals, advancing the field of coordination chemistry and its potential applications in medicine and environmental science.
Muhammad Asif, Ph.D.
Associate Professor, The Islamia University of Bahawalpur, Pakistan
Dr. Muhammad Asif, an accomplished pharmacologist, serves as an Associate Professor in the Department of Pharmacology, Faculty of Pharmacy, The Islamia University of Bahawalpur, Pakistan. A Higher Education Commission (HEC)-approved supervisor, he has a PharmD and MPhil in Pharmacology from The Islamia University of Bahawalpur and a PhD in Pharmacology from Universiti Sains Malaysia. Dr. Asif has expertise in pharmacological screening, bioactive compound isolation, and nanoformulations, supported by extensive experience with advanced instrumentation. With 104 research articles, 2,068 citations, and multiple national and international awards, his work exemplifies leadership in drug discovery and herbal medicine research.
Saad Sabbar Dahham, Ph.D.
Associate Professor, Rustaq College, Oman
Dr. Saad Sabbar Dahham is an Associate Professor, at the University of Technology and Applied Sciences, Rustaq, Oman, specializing in cancer biology and microbiology. His work focuses on natural compounds with anticancer, antimicrobial, and antioxidant properties, particularly from Aquilaria crassna, Punica granatum, and Terfezia claveryi. Dr. Dahham's research has significantly contributed to understanding bioactive essential oils and their therapeutic applications, including β-caryophyllene's potential in cancer treatment. With a robust publication record in leading journals, his studies bridge molecular biology, pharmacology, and traditional medicine, advancing innovative strategies for cancer prevention and treatment through natural and sustainable approaches.
Malek Zihlif, Ph.D.
Associate Professor, University of Jordan, Jordan
Dr. Malek Zihlif, a faculty member in the Department of Pharmacology at the University of Jordan, specializes in pharmacogenomics, cancer biology, and drug resistance. He investigated the genetic and molecular mechanisms underlying cancer progression, with significant contributions to understanding doxorubicin resistance and hypoxia-induced gene expression in breast cancer. Dr. Zihlif has explored innovative anticancer therapies, including bioactive compounds and liposomal drug delivery systems, earning widespread recognition with nearly 200 citations for his pioneering study on MCF7 cell lines. A prolific researcher, he actively collaborates on projects advancing personalized medicine and novel therapeutic strategies in oncology and pharmacology.
Mouayed A. Hussein, Ph.D.
Professor University of Basrah, Iraq
Professor Dr. Mouayed A. Hussein is a distinguished academic in the fields of photochemistry, inorganic chemistry, and medicinal chemistry. He holds a professorship at the University of Basrah, Iraq, and has made significant contributions to the synthesis and characterization of metal complexes with biological applications. His research focuses on the anticancer, pro-apoptotic, and anti-metastatic properties of metal-based complexes, particularly binuclear silver(I)–N-heterocyclic carbene complexes. Prof. Hussein's work has resulted in multiple publications in high-impact journals, highlighting his expertise in DNA binding, cleavage, and antitumor activities. He continues to explore innovative approaches in the development of therapeutic agents.
Maryam Keshavarzi, Ph.D.
Assistant Professor, Alzahra University
Iran
Mohsen Naseri, Ph.D.
Assistant Professor, Shahed University
Iran
Publisher
Md Shamsuddin Sultan Khan, CEO
Email shams.sultankhan@emanresearch.org
For Advertising, Commercial Reprint, and/or Recruitment Information
- Visit ER's Advertising Center
Marketing Manager
- office@emanresearch.org
Translation, Rights & Licensing
- office@emanresearch.org
Eman Research Business Offices
Eman Research Publishng LLC, 30 N Gould St Ste R Sheridan, WY 82801 USA
E-mail: office@emanresearch.org
Website https://publishing.emanresearch.org
Submit Article
Use the online submission system to send us your manuscript.
Call for Papers
We are seeking Contributions for a special issue. More.
Best Paper Award
Authors are awarded for Best Paper for this Journal Annually
Advertisement